×
About 7,748 results

ALLMedicine™ Intravenous Immunoglobulin Center

Research & Reviews  2,663 results

Recurrent parvovirus B19 viremia resulting in two episodes of hemophagocytic lymphohist...
https://doi.org/10.1186/s12985-022-01841-y 10.1111/bjh.14147 10.1002/pbc.21039 10.1002/art.38690 10.1002/1097-0142(197909)44:3<993::AID-CNCR2820440329>3.0.CO;2-5 10.1016/S1473-3099(07)70290-6 10.1002/ccr3.2401 10.1016/S0140-6736(95)91673-3 10.1186/1471-2334-10-246 10.3389/fcimb.2020.00202 10.2147/TCRM.S195538
Virology Journal; Orth HM, Fuchs A et. al.

Jun 26th, 2022 - Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory condition with uncontrolled activation of lymphocytes and macrophages. Besides a primary (genetic) form, HLH can also be triggered by malignant, autoimmune and infectious diseases. HL...

Hizentra® in Inflammatory Neuropathies - pHeNIx Study
https://clinicaltrials.gov/ct2/show/NCT04672733

Jun 24th, 2022 - Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a neurological and rare type of autoimmune disorder. Intravenous immunoglobulin (IVIg) is the first-line treatment for CIDP which has been proven to be effective. For several years, publi...

Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
https://clinicaltrials.gov/ct2/show/NCT05350774

Jun 24th, 2022 - Study Description: This study will evaluate the clinical and laboratory effects of immunotherapies in patients who recovered from acute mildmoderate COVID-19 infection but still have persistent neurologic symptoms. Despite clinical recovery from t...

Human Encephalitis Caused by Pseudorabies Virus in China: A Case Report and Systematic ...
https://doi.org/10.1089/vbz.2022.0002
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.); Hou Y, Wang Y et. al.

Jun 24th, 2022 - Background: Pseudorabies virus (PRV) is a common pathogen found in pigs. The pathogenicity of PRV in humans is under researched and there are few confirmed cases of PRV infections in humans, which has led to a lack of clinical consensus. Methods: ...

Hemophagocytic Lymphohistiocytosis Associated With Hemolytic Uremic Syndrome in a Child...
https://doi.org/10.1097/MPH.0000000000002265
Journal of Pediatric Hematology/oncology; Tas N, Gokceoglu AU et. al.

Jun 23rd, 2022 - Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disorder resulting from excessive activation and nonmalignant proliferation of T-lymphocytes and macrophages. Hemolytic uremic syndrome (HUS) is a disease characterized by microangiopa...

see more →

Guidelines  2 results

European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatol...
https://doi.org/10.1111/jdv.13725
Journal of the European Academy of Dermatology and Venere... Enk AH, Hadaschik EN et. al.

Oct 21st, 2016 - The treatment of severe dermatological autoimmune diseases and toxic epidermal necrolysis (TEN) with high-dose intravenous immunoglobulin (IVIg) is a well-established procedure in dermatology. As treatment with IVIg is usually considered for rare ...

European Federation of Neurological Societies/Peripheral Nerve Society guideline on man...
https://doi.org/10.1111/j.1468-1331.2009.02930.x
European Journal of Neurology; Van den Bergh PY, Hadden RD et. al.

May 12th, 2010 - Consensus guidelines on the definition, investigation, and treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) have been previously published in European Journal of Neurology and Journal of the Peripheral Nervous System. ...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  203 results

Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
https://clinicaltrials.gov/ct2/show/NCT05350774

Jun 24th, 2022 - Study Description: This study will evaluate the clinical and laboratory effects of immunotherapies in patients who recovered from acute mildmoderate COVID-19 infection but still have persistent neurologic symptoms. Despite clinical recovery from t...

Hizentra® in Inflammatory Neuropathies - pHeNIx Study
https://clinicaltrials.gov/ct2/show/NCT04672733

Jun 24th, 2022 - Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a neurological and rare type of autoimmune disorder. Intravenous immunoglobulin (IVIg) is the first-line treatment for CIDP which has been proven to be effective. For several years, publi...

A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
https://clinicaltrials.gov/ct2/show/NCT04656184

Jun 21st, 2022 - It is a multicentric national randomized controlled, parallel-group in a 1:1 ratio, open labelled trial of superiority. The main objective is to compare the efficacy of Anakinra (Interleukin 1 receptor type 1 - receptor antagonist) with 2nd IVIG i...

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults
https://clinicaltrials.gov/ct2/show/NCT05422365

Jun 16th, 2022 - The investigational drug, IVIG, is used for immunomodulatory therapy in the treatment of autoimmune diseases. The study will involve patients with chronic immune thrombocytopenia. This autoimmune disease is diagnosed in the presence of isolated th...

A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
https://clinicaltrials.gov/ct2/show/NCT05363358

Jun 15th, 2022 - The main aim of this study is to evaluate the rates of adverse events of special interest (AESIs) (thrombotic events, acute kidney injury [AKI], and hemolytic events) among participants with CIDP initiating GGL compared with rates among participan...

see more →

News  227 results

Intravenous Immunoglobulin in Treating Nonventilated COVID-19 Patients With Moderate-to-Severe Hypoxia: A Pharmacoeconomic Analysis
https://www.mdedge.com/jcomjournal/article/255043/covid-19-updates/intravenous-immunoglobulin-treating-nonventilated-covid
Matthew Poremba, PharmD, Matthew Dehner, PharmD et. al.

May 27th, 2022 - From Sharp Memorial Hospital, San Diego, CA (Drs. Poremba, Dehner, Perreiter, Semma, and Mills), Sharp Rees-Stealy Medical Group, San Diego, CA (Dr.

ITP Armamentarium Expands With the Hope of Limiting Long-Term Steroid Exposure
https://www.onclive.com/view/itp-armamentarium-expands-with-the-hope-of-limiting-long-term-steroid-exposure

Apr 18th, 2022 - Although patients with primary and secondary immune thrombocytopenia (ITP) can derive good responses from corticosteroids, long-term exposure to steroids is associated with unique adverse effects (AEs), said Kanwarpal S. Kahlon, MD, who added that...

What Drives Post-COVID Cognitive Changes?
https://www.medpagetoday.com/neurology/generalneurology/97981

Apr 1st, 2022 - New research released today suggested that an over-stimulated immune system -- possibly triggered by ongoing vascular injury and repair -- may be behind persistent post-COVID cognitive changes. In preliminary work that will be presented at the Ame...

Kawasaki Disease Guideline Highlights Rheumatology Angles
https://www.medscape.com/viewarticle/970815

Mar 23rd, 2022 - All Kawasaki disease (KD) patients should be treated first with intravenous immunoglobulin, according to an updated guideline issued jointly by the American College of Rheumatology and the Vasculitis Foundation. Dr Mark Gorelik KD has low mortalit...

Kawasaki disease guideline highlights rheumatology angles
https://www.mdedge.com/rheumatology/article/252902/pediatrics/kawasaki-disease-guideline-highlights-rheumatology-angles
Heidi Splete

Mar 18th, 2022 - All Kawasaki disease (KD) patients should be treated first with intravenous immunoglobulin, according to an updated guideline issued jointly by the American College of Rheumatology and the Vasculitis Foundation. KD has low mortality when treated a.

see more →

Patient Education  2 results see all →